Head to Head Survey: Prenetics Global (NASDAQ:PRE) versus Lifevantage (NASDAQ:LFVN)

Prenetics Global (NASDAQ:PRE) and Lifevantage (NASDAQ:LFVN) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Risk and Volatility

Prenetics Global has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, Lifevantage has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

Valuation & Earnings

This table compares Prenetics Global and Lifevantage”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39 million	4.42	-$37.71 million	($4.16)	-5.81
Lifevantage	$182.59 million	0.44	$5.07 million	$0.40	15.87

Lifevantage has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Prenetics Global and Lifevantage’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-47.43%	-21.41%	-15.56%
Lifevantage	2.78%	21.56%	11.62%

Institutional and Insider Ownership

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 35.3% of Lifevantage shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by company insiders. Comparatively, 22.0% of Lifevantage shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for Prenetics Global and Lifevantage, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1	0	6	0	2.71
Lifevantage	0	2	0	0	2.00

Prenetics Global presently has a consensus target price of $35.67, suggesting a potential upside of 47.44%. Lifevantage has a consensus target price of $5.50, suggesting a potential downside of 13.39%. Given Prenetics Global’s stronger consensus rating and higher possible upside, analysts clearly believe Prenetics Global is more favorable than Lifevantage.

Summary

Lifevantage beats Prenetics Global on 10 of the 14 factors compared between the two stocks.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.